HSP70, a Novel Regulatory Molecule in B Cell-Mediated Suppression of Autoimmune Diseases

B cells have recently emerged as playing regulatory role in autoimmune diseases. We have previously demonstrated that human peripheral blood CD19(+)CD24(hi)CD27(+) B cells have regulatory function both in healthy donors and in patients with autoimmune disease. However, the mechanism of this regulation is still not fully understood. In this study, microarrays were utilized to compare gene expression of CD19(+)CD24(hi)CD27(+) B cells (regulatory B cells, Bregs) with CD19(+)CD24(1o)CD27(-) B cells (non-Bregs) in human peripheral blood. We found that heat shock protein 70 (HSP70) expression was significantly upregulated in Bregs. In vitro studies explored that HSP70 inhibition impaired the regulatory function of peripheral blood Bregs. In mouse models of autoimmune disease, using HSP70-deficient mice or HSP70 inhibitors, Bregs suppressed effector cells and rescued disease-associated phenotypes that were dependent on HSP70. Mechanistically, Bregs secreted HSP70, directly suppressing effector cells, such as T effect cells. These findings reveal that HSP70 is a novel factor that modulates Breg function and suggest that enhancing Breg-mediated production of HSP70 could be a viable therapy for autoimmune disease. (C) 2020 The Authors. Published by Elsevier Ltd.

Automated summary

The study revealed a close association between B cell regulatory function and heat shock protein 70 (HSP70) content in autoimmune diseases, where Bregs directly suppressed effector cells by secreting HSP70. These findings provide theoretical basis for enhancing Breg-mediated production of HSP70 as a novel strategy for treating autoimmune diseases.